This Clinical Investigation Assesses the Safety and Performance of a New Beamformer for MED-EL Cochlear Implant Recipients.

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Cochlear Implant Users
Interventions
OTHER

Testing new front-end features

New front-end features (i,e, the Focused Beamformer which nhances directional hearing and the AI Mode Medium (utilizes artificial intelligence for optimized sound processing) will be compared to the approved beamformer and AI mode) in a within subject design. Subjects will be fitted with a MED-EL SONNET 3 audio processor.

Trial Locations (2)

Unknown

Medizinische Universität Innsbruck, Universitätsklinik für Hör-, Stimm-, und Sprachstörungen, Innsbruck

Universitätsklinikum St. Pölten, Abteilung für Hals-, Nasen- und Ohrenerkrankungen, Sankt Pölten

All Listed Sponsors
collaborator

Medizinische Universität Innsbruck, Universitätsklinik für Hör-, Stimm-, und Sprachstörungen

UNKNOWN

collaborator

Universitätsklinikum St. Pölten - NÖ Landeskliniken, Universitätsklinikum für Hals-, Nasen-, Ohrenkrankheiten

UNKNOWN

lead

MED-EL Elektromedizinische Geräte GesmbH

INDUSTRY

NCT07213505 - This Clinical Investigation Assesses the Safety and Performance of a New Beamformer for MED-EL Cochlear Implant Recipients. | Biotech Hunter | Biotech Hunter